Aprogen Biologics Inc.

KOSE:A003060 Lagerbericht

Marktkapitalisierung: ₩142.3b

Aprogen Biologics Management

Management Kriterienprüfungen 0/4

Wir verfügen derzeit nicht über ausreichende Informationen über den CEO.

Wichtige Informationen

Jeong-Chool Kim

Geschäftsführender

n/a

Gesamtvergütung

Prozentsatz des Geschäftsführergehaltsn/a
Amtszeit als Geschäftsführerno data
Eigentum des Geschäftsführersn/a
Durchschnittliche Amtszeit des Managementskeine Daten
Durchschnittliche Amtszeit der Vorstandsmitgliederkeine Daten

Jüngste Management Updates

Recent updates

Risks Still Elevated At These Prices As Aprogen Biologics Inc. (KRX:003060) Shares Dive 26%

Jun 20
Risks Still Elevated At These Prices As Aprogen Biologics Inc. (KRX:003060) Shares Dive 26%

More Unpleasant Surprises Could Be In Store For Aprogen Biologics Inc.'s (KRX:003060) Shares After Tumbling 28%

Apr 18
More Unpleasant Surprises Could Be In Store For Aprogen Biologics Inc.'s (KRX:003060) Shares After Tumbling 28%

We Wouldn't Rely On Aprogen pharmaceuticalsInc's (KRX:003060) Statutory Earnings As A Guide

Jan 16
We Wouldn't Rely On Aprogen pharmaceuticalsInc's (KRX:003060) Statutory Earnings As A Guide

Aprogen pharmaceuticals,Inc.'s (KRX:003060) Financials Are Too Obscure To Link With Current Share Price Momentum: What's In Store For the Stock?

Dec 20
Aprogen pharmaceuticals,Inc.'s (KRX:003060) Financials Are Too Obscure To Link With Current Share Price Momentum: What's In Store For the Stock?

Is Aprogen pharmaceuticalsInc (KRX:003060) A Risky Investment?

Nov 24
Is Aprogen pharmaceuticalsInc (KRX:003060) A Risky Investment?

Geschäftsführer

Jeong-Chool Kim

no data

Amtszeit

Jeong-Chool Kim serves as the Chief Operating Officer of Aprogen, Inc. Jeong Chul Kim serves as Chief Executive Officer of Gen-Exel Medical Inc. and Aprogen pharmaceuticals,Inc. (formerly known as Schnell...